Economic development creates opportunities to grow state, local and metro areas, which are essential for economic growth, improved quality of life and community development. biopharmaceutical articles below.
Biopharmaceutical company Gilead Sciences, Inc. will invest up to $5 million in North Carolina’s Research Triangle region.
INCOG BioPharma Services will invest $60M to establish its first manufacturing facility and global headquarters in Fishers, IN.
The pharmaceutical company will establish its first U.S. manufacturing facility in Indianapolis and plans to create more than 100 new, high-wage jobs by the end of 2024.
The German company, which operates its biopharm business as EMD Serono in the U.S. and Canada, will invest $70 million to expand its Billerica, MA facility.
Investment supports growing demand with new biopharmaceutical manufacturing and distribution centers in South Korea and India, accelerates biosimilars manufacturing and development in China.